Literature DB >> 72789

Vincristine polyneuropathy in man. A clinical and electrophysiological study.

M R Caccia, B Comotti, E Ubiali, A Lucchetti.   

Abstract

A clinical and electrophysiological follow up study of 14 cases of hemopathic patients patients undergoing VCR therapy showed evidence that the drug has a direct action on the motor and sensory axon but not on the propagation velocity. Sensory nerves seem to be affected earlier and more than motor ones. Correlation was good between clinical and electrophysiological findings for both functions. The findings in man correspond with the animal data and therefore lead to the conclusion that VCR polyneuropathy is due to an involvement of the nerve axon.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 72789     DOI: 10.1007/BF00312811

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  14 in total

1.  Additive toxicity of vincristine and other drugs for the peripheral nervous system. Three case reports.

Authors:  J Hildebrand; Y Kenis
Journal:  Acta Neurol Belg       Date:  1971       Impact factor: 2.396

2.  The neuromyopathy of vincristine in man. Clinical, electrophysiological and pathological studies.

Authors:  W G Bradley; L P Lassman; G W Pearce; J N Walton
Journal:  J Neurol Sci       Date:  1970-02       Impact factor: 3.181

3.  Fast axonal transport in vitro in the sciatic system of the frog.

Authors:  A Edstrom; H Mattsson
Journal:  J Neurochem       Date:  1972-01       Impact factor: 5.372

4.  Vinca alkaloid neuropathy: nerve biopsy studies in rats and in man.

Authors:  P G Gottschalk; P J Dyck; J M Kiely
Journal:  Neurology       Date:  1968-09       Impact factor: 9.910

5.  Vincristine neuropathy: an electrophysiological and histological study.

Authors:  J G McLeod; R Penny
Journal:  J Neurol Neurosurg Psychiatry       Date:  1969-08       Impact factor: 10.154

6.  Trophic functions of the neuron. 3. Mechanisms of neurotrophic interactions. The effects of vinblastine and colchicine on neural regulation of muscle.

Authors:  E X Albuquerque; J E Warnick; F M Sansone; R Onur
Journal:  Ann N Y Acad Sci       Date:  1974-03-22       Impact factor: 5.691

7.  Vincristine neurotoxicity.

Authors:  P L Weiden; S E Wright
Journal:  N Engl J Med       Date:  1972-06-22       Impact factor: 91.245

8.  Vincristine in acute leukemia of childhood.

Authors:  M E Haggard; D J Fernbach; T M Holcomb; W W Sutow; T J Vietti; J Windmiller
Journal:  Cancer       Date:  1968-08       Impact factor: 6.860

9.  Vincristine-induced neuropathy. A clinical study of fifty leukemic patients.

Authors:  S G Sandler; W Tobin; E S Henderson
Journal:  Neurology       Date:  1969-04       Impact factor: 9.910

10.  Studies on the microtubules in heliozoa. IV. The effect of colchicine on the formation and maintenance of the axopodia and the redevelopment of pattern in Actinosphaerium nucleofilum (Barrett).

Authors:  L G Tilney
Journal:  J Cell Sci       Date:  1968-12       Impact factor: 5.285

View more
  4 in total

1.  Sural nerve conduction in mild polyneuropathy.

Authors:  M C Kayser-Gatchalian; B Neundörfer
Journal:  J Neurol       Date:  1984       Impact factor: 4.849

2.  Vindesine. A clinical trial with special reference to neurological side effects.

Authors:  R Obrist; U Paravicini; D Hartmann; G A Nagel; J P Obrecht
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

3.  Retardation of rat sciatic nerve regeneration after local application of minute doses of vincristine.

Authors:  G S Ruigt; M H den Brok
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

Review 4.  Prevention and management of drug-induced peripheral neuropathy.

Authors:  L L Olesen; T S Jensen
Journal:  Drug Saf       Date:  1991 Jul-Aug       Impact factor: 5.606

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.